167 related articles for article (PubMed ID: 37121771)
41. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review.
Duan H; Gao W; Wang L; Cao F; Teng L
Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
[TBL] [Abstract][Full Text] [Related]
42. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
[TBL] [Abstract][Full Text] [Related]
43. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
Chatzopoulos K; Boland JM
Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
[TBL] [Abstract][Full Text] [Related]
44. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases].
Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309
[No Abstract] [Full Text] [Related]
45. Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression.
Early CA; Wangsiricharoen S; Jones RM; VandenBussche CJ
J Am Soc Cytopathol; 2021; 10(2):197-207. PubMed ID: 32893180
[TBL] [Abstract][Full Text] [Related]
46. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
Wang J; Elghawy O; Kurpiel B; Kaur V
Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
[TBL] [Abstract][Full Text] [Related]
48. Thoracic SMARCA4-deficient undifferentiated tumor with associated granulomatous reaction and response to pembrolizumab.
Marshall M; Khader S; Beasley S; Lajara S
Diagn Cytopathol; 2023 Oct; 51(10):E287-E293. PubMed ID: 37350425
[TBL] [Abstract][Full Text] [Related]
49. Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
Gantzer J; Davidson G; Vokshi B; Weingertner N; Bougoüin A; Moreira M; Lindner V; Lacroix G; Mascaux C; Chenard MP; Bertucci F; Davidson I; Kurtz JE; Sautès-Fridman C; Fridman WH; Malouf GG
Oncologist; 2022 Jun; 27(6):501-511. PubMed ID: 35278076
[TBL] [Abstract][Full Text] [Related]
50. SMARCA4-Deficient Undifferentiated Tumor Diagnosed on Adrenal Sampling.
Ashour S; Reynolds JP; Mukhopadhyay S; McKenney JK
Am J Clin Pathol; 2022 Jan; 157(1):140-145. PubMed ID: 34463317
[TBL] [Abstract][Full Text] [Related]
51. Fine needle aspiration cytology of metastatic SMARCA4-deficient sinonasal teratocarcinosarcoma: First report in literature.
Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
[TBL] [Abstract][Full Text] [Related]
52. SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C; Le Loarer F
Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
[TBL] [Abstract][Full Text] [Related]
53. SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report.
Meda Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Kiriyama A; Fujino M
Clin J Gastroenterol; 2022 Apr; 15(2):419-426. PubMed ID: 35129794
[TBL] [Abstract][Full Text] [Related]
54. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
55. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
Matsushita M; Kuwamoto S
Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
[TBL] [Abstract][Full Text] [Related]
56. Thoracic SMARCA4-Deficient Undifferentiated Tumors With Unusual Presentations: A Case Series.
Helmink AJ; Alshomrani A; Lauer SR; Yuil-Valdes A
Int J Surg Pathol; 2023 Oct; ():10668969231206350. PubMed ID: 37903457
[TBL] [Abstract][Full Text] [Related]
57. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
[TBL] [Abstract][Full Text] [Related]
58. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
[TBL] [Abstract][Full Text] [Related]
59. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
Kawachi H; Kunimasa K; Kukita Y; Nakamura H; Honma K; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Mizote Y; Akazawa T; Tahara H; Kumagai T
Immunotherapy; 2021 Jul; 13(10):799-806. PubMed ID: 34030451
[TBL] [Abstract][Full Text] [Related]
60. Positron emission tomography/computed tomography hypermetabolism of Kikuchi-Fujimoto disease mimicking malignant lymphoma: a case report and literature review.
Wang S; Du B; Li X; Li Y
J Int Med Res; 2021 Jul; 49(7):3000605211032859. PubMed ID: 34334002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
